FDA authorizes bivalent COVID-19 boosters for children ages 5 to 11
The FDA authorized the COVID-19 boosters for children under 12 Wednesday morning from both Pfizer-BioNTech and Moderna
Wednesday, October 12, 2022 at 2:04 pm